| - GRCh37:
- Chr2:47643435
- GRCh38:
- Chr2:47416296
| MSH2 | G249C, G315C | Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47637507-47637508
- GRCh38:
- Chr2:47410368-47410369
| MSH2 | R148fs, R214fs | Mismatch repair cancer syndrome 2, Hereditary nonpolyposis colorectal neoplasms | Pathogenic/Likely pathogenic (Jan 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47698130
- GRCh38:
- Chr2:47470991
| MSH2 | Y497C, Y563C | Hereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome, Lynch syndrome 1, Mismatch repair cancer syndrome 2, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Aug 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47703565
- GRCh38:
- Chr2:47476426
| MSH2 | A623T, A689T | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms | Conflicting interpretations of pathogenicity (Mar 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47693958
- GRCh38:
- Chr2:47466819
| MSH2 | | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Mismatch repair cancer syndrome 2, Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, not specified
| Likely benign (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47690237
- GRCh38:
- Chr2:47463098
| MSH2 | M485T, M419T | Hereditary cancer-predisposing syndrome, Lynch syndrome 1, Mismatch repair cancer syndrome 2, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms | Conflicting interpretations of pathogenicity (Mar 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47693947
- GRCh38:
- Chr2:47466808
| MSH2 | S554N, S488N | Lynch syndrome 1, Mismatch repair cancer syndrome 2, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 1
| Pathogenic/Likely pathogenic (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47643484
- GRCh38:
- Chr2:47416345
| MSH2 | N331S, N265S | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome, Hereditary cancer-predisposing syndrome, not specified, Lynch syndrome 1, Muir-Torré syndrome, Mismatch repair cancer syndrome 2 | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47702296
- GRCh38:
- Chr2:47475157
| MSH2 | R631K, R565K | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided
| Conflicting interpretations of pathogenicity (May 25, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47672764
- GRCh38:
- Chr2:47445625
| MSH2 | E452K, E386K | Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47630206-47656880
- GRCh38:
- Chr2:47403067-47429741
| MSH2 | | Lynch syndrome | Pathogenic (Jan 15, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47690263
- GRCh38:
- Chr2:47463124
| MSH2 | S494P, S428P | not provided, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Feb 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47705460
- GRCh38:
- Chr2:47478321
| MSH2 | T754S, T688S | Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, not specified | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47637374
- GRCh38:
- Chr2:47410235
| MSH2 | Q170E, Q104E | not specified, Lynch syndrome 1, Lynch syndrome 1, Muir-Torré syndrome, Mismatch repair cancer syndrome 2, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47705460
- GRCh38:
- Chr2:47478321
| MSH2 | T754A, T688A | Mismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided, Lynch syndrome 1 | Conflicting interpretations of pathogenicity (Mar 30, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47630403
- GRCh38:
- Chr2:47403264
| MSH2 | G25C | Muir-Torré syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Jun 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47630150
- GRCh38:
- Chr2:47403011
| MSH2 | | Lynch syndrome, Muir-Torré syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided, Lynch syndrome 1 | Uncertain significance (Apr 12, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:47637432
- GRCh38:
- Chr2:47410293
| MSH2 | A189G, A123G | Hereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Hereditary cancer-predisposing syndrome, not specified, not provided, Lynch syndrome 1 | Conflicting interpretations of pathogenicity (Jun 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47630496
- GRCh38:
- Chr2:47403357
| MSH2 | E56K | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Mismatch repair cancer syndrome 2, Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, not specified, not provided | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47635548
- GRCh38:
- Chr2:47408409
| MSH2 | N74H, N8H | Mismatch repair cancer syndrome 2, Muir-Torré syndrome, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified, not provided, Lynch syndrome 1 | Conflicting interpretations of pathogenicity (Jun 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47637476
- GRCh38:
- Chr2:47410337
| MSH2 | G204R, G138R | Muir-Torré syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1, Hereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 | Conflicting interpretations of pathogenicity (Mar 21, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47643483
- GRCh38:
- Chr2:47416344
| MSH2 | N331D, N265D | Lynch syndrome 1 | Uncertain significance (Jun 13, 2018) | reviewed by expert panel |
| - GRCh37:
- Chr2:47630427
- GRCh38:
- Chr2:47403288
| MSH2 | T33P | Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Mismatch repair cancer syndrome 2, Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, not provided, not specified, Lynch syndrome 1 | Conflicting interpretations of pathogenicity (Mar 21, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47637509
- GRCh38:
- Chr2:47410370
| MSH2 | Q215*, Q149* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47637371
- GRCh38:
- Chr2:47410232
| MSH2 | I169V, I103V | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47635601-47635603
- GRCh38:
- Chr2:47408462-47408464
| MSH2 | L94del, L28del | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47630353
- GRCh38:
- Chr2:47403214
| MSH2 | T8M | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47703501
- GRCh38:
- Chr2:47476362
| MSH2 | | Mismatch repair cancer syndrome 2 | Pathogenic (Feb 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr2:47630331
- GRCh38:
- Chr2:47403192
| MSH2 | M1L | Lynch syndrome | Uncertain significance (Jun 21, 2019) | reviewed by expert panel |
| - GRCh37:
- Chr2:47702290
- GRCh38:
- Chr2:47475151
| MSH2 | Q629R, Q563R | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47698132
- GRCh38:
- Chr2:47470993
| MSH2 | T564A, T498A | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47698122
- GRCh38:
- Chr2:47470983
| MSH2 | | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47698103
- GRCh38:
- Chr2:47470964
| MSH2 | | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47693948
- GRCh38:
- Chr2:47466809
| MSH2 | | Lynch syndrome | Likely pathogenic (Jun 21, 2019) | reviewed by expert panel |
| - GRCh37:
- Chr2:47630468
- GRCh38:
- Chr2:47403329
| MSH2 | H46Q | Lynch syndrome | Likely benign (Dec 19, 2018) | reviewed by expert panel |
| - GRCh37:
- Chr2:47657081
- GRCh38:
- Chr2:47429942
| MSH2 | | Lynch syndrome | Likely pathogenic (Jun 21, 2019) | reviewed by expert panel |
| - GRCh37:
- Chr2:47657059
- GRCh38:
- Chr2:47429920
| MSH2 | Q419K, Q353K | Lynch syndrome | Likely benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47656969
- GRCh38:
- Chr2:47429830
| MSH2 | R389*, R323* | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47637246
- GRCh38:
- Chr2:47410107
| MSH2 | N127S, N61S | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47703500
- GRCh38:
- Chr2:47476361
| MSH2 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47698108
- GRCh38:
- Chr2:47470969
| MSH2 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47693788
- GRCh38:
- Chr2:47466649
| MSH2 | | Lynch syndrome | Benign (Sep 5, 2013) | reviewed by expert panel |
| - GRCh37:
- Chr2:47637317
- GRCh38:
- Chr2:47410178
| MSH2 | M86fs, M152fs | Lynch syndrome | Pathogenic (Sep 5, 2013) | reviewed by expert panel |